PRUnderground

Study: Infectious HPV Virus Found on Most Clean Public Toilet Seats; CBCD Reviews Study


Warning: DOMDocument::loadHTML(): htmlParseEntityRef: no name in Entity, line: 16 in /home/dev/public_html/wp-content/themes/pru2.0/amp/single.php on line 52

Warning: DOMDocument::loadHTML(): htmlParseEntityRef: no name in Entity, line: 16 in /home/dev/public_html/wp-content/themes/pru2.0/amp/single.php on line 52

Dr. Vitaly Smelov, from the Department of Laboratory Medicine at Karolinska Institutet, Sweden, and colleagues tested clean public toilet seats for the presence of human papillomavirus (HPV). They found that 89% of the sampled seats had the virus! Most of the surfaces they tested, such as toilet seats, which contact anogenital skin (the bottom and/or genitals) in public restrooms, were positive for the presence of HPV, the virus that causes genital warts and cancer. According to the study, “Apparently clean seats in 23 airports located in 13 countries (Belgium, Denmark, Finland, France, Germany, Italy, Jordan, the Netherlands, Russia, Sweden, Switzerland, Spain and UK) were sampled with (an advanced DNA testing procedure). (The procedure) detected (HPV) DNA in 101/113 (89%) of samples.” What makes these statistics even worse is the fact that the HPV virus can stay infectious for up to 7 days. “STI (sexually transmitted infection) particles deposited on environmental surfaces may stay temporarily infectious: … up to 7 days for HPV.” (1)

The conclusion is clear. Every day, thousands of people risk an infection with the human papillomavirus (HPV) when they use a public toilet.

“The potential for becoming infected with HPV, the virus that can cause genital warts or cancer, just by sitting on a public toilet seat is frightening.” – John Evans, CBCD

The CBCD recommends that people who use public toilet seats take Gene-Eden-VIR or Novirin. The formula of these natural antiviral products was tested by Hanan Polansky and Edan Itzkovitz from the CBCD in two clinical studies that followed FDA guidelines. The studies showed that the Gene-Eden-VIR and Novirin formula is effective against the HPV and other viruses. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, “individuals infected with the HPV…reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR.” (2) The study authors also wrote that, “we observed a statistically significant decrease in the severity, duration, and frequency of symptoms.” (2)

Both products can be ordered online on the Gene-Eden-VIR and Novirin websites.

Gene-Eden-VIR and Novirin are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Gene-Eden-VIR and Novirin are the only natural antiviral products on the market with published clinical studies that support their claims.

Click to learn more about Gene-Eden-VIR and HPV.

References:

(1) Smelov V, Eklund C, Arroyo Muhr LS, Hultin E, Dillner J. Are human papillomavirus DNA prevalences providing high-flying estimates of infection? An international survey of HPV detection on environmental surfaces.  Sex Transm Infect. 2013 Dec;89(8):627. doi: 10.1136/sextrans-2013-051280. Epub 2013 Nov 4.

(2) Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published on August 12, 2013. 

About CBCD

About CBCD

The Center for the Biology of Chronic Disease (https://www.cbcd.net) is a not-for-profit tax-exempt organization under section 501(c) 3 of the IRS tax code. The center’s mission is to advance the research on the biology of chronic disease and to accelerate the discovery of a cure for these diseases. The CBCD first published Dr. Hanan Polansky’s highly acclaimed “Purple” book, entitled “Microcompetition with Foreign DNA and the Origin of Chronic Disease” in 2003. In this book, he explains how foreign DNA fragments can cause many major diseases. The book has been read by more than 5,000 scientists around the world, and has been reviewed in more than 20 leading scientific journals. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Become a Fan

Press Contact

Image Gallery

Name: Mike Evans
Phone: 585-250-9999
Website: https://www.gene-eden-vir.com